Showing results (11-20 of 133) with videos related to
Sort By:
Pageof 14
Future Medicinal Chemistry|June 6, 2013
Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivityAnnerleim Walton-Diaz, Sahar Khan, Dimitra Bourboulia, et al.Molecular Cancer Therapeutics|January 7, 2005
Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatmentMona S Jhaveri, Antonina S Rait, Koong-Nah Chung, et al.Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Clinical Evaluation and Biomarker Profiling of Hsp90 InhibitorsAkira Yuno, Min-Jung Lee, Sunmin Lee, et al.Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.Cell Stress & Chaperones|June 15, 2024
An update on the status of HSP90 inhibitors in cancer clinical trialsShraddha Rastogi, Abhinav Joshi, Nahoko Sato, et al.Journal of Translational Medicine|July 23, 2015
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancerJung-Min Lee, Nicolas Gordon, Jane B Trepel, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2012
Methoxychalcone inhibitors of androgen receptor translocation and functionYeong Sang Kim, Vineet Kumar, Sunmin Lee, et al.Medical Oncology (Northwood, London, England)|April 27, 2017
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancerBryan Oronsky, Carolyn M Ray, Alexander I Spira, et al.Journal of Neurochemistry|October 25, 2006
PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMPJay H Chang, Deepika Vuppalanchi, Erna van Niekerk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (<i>SLFN11)</i> Expression with Class I Histone Deacetylase InhibitorsSai-Wen Tang, Anish Thomas, Junko Murai, et al.Pageof 14